Skip to Main Content

Paper Details

Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Neuro Oncol
69
2013
ERCC1, GBM, MGMT, MLH1, MSH2, O(6)-methylguanine, O(6)-methylguanine-DNA methyltransferase, Patients, glioblastoma, men, neutropenia, participants, patients, temozolomide, thrombocytopenia, tumors

Datasets